ArticleSAGE open medical case reports2026
Uterine artery embolization for fibroid-induced hydronephrosis in a renal transplant recipient.
Article in SAGE open medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obstructive uropathy from uterine fibroids is recognized in the general population but is rare in renal transplant recipients. We report the first case, to our knowledge, of uterine artery embolization successfully treating fibroid-induced hydronephrosis of a transplanted kidney. A woman with a prior renal transplant presented with urinary symptoms and anemia due to menorrhagia from uterine fibroids. Imaging revealed a markedly leiomyomatous uterus causing transplant ureteral compression with hydronephrosis. Uterine artery embolization was performed without traversing the transplant arterial anastomosis. At 4 weeks postintervention, hemoglobin levels improved from 7.1 to 11.4 g/dL. Subsequent magnetic resonance imaging performed 6 months after therapy confirmed a 34% reduction in uterine volume and resolution of hydronephrosis. Renal function remained stable. Uterine artery embolization may be a feasible treatment option for fibroid-induced hydronephrosis in selected renal transplant patients, with symptom resolution and preservation of allograft function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.